CAHR Abstracts 2006
MAIN MENU
CLINICAL SCIENCES: ORAL PRESENTATIONS - HIV THERAPY AND RESISTANCE
207 - SUBTYPE C HIV-1 ISOLATES RAPIDLY SELECT FOR K65R RESISTANCE WITH TENOFOVIR IN TISSUE CULTURE
208 - COMBINED NEVIRAPINE AND ZIDOVUDINE COMPARED TO NEVIRAPINE ALONE IN PREVENTION OF PERINATAL HIV TRANS...
209 - EARLY IMMUNOLOGIC AND VIROLOGIC RESPONSE PREDICTS CLINICAL OUTCOME IN LATE SALVAGE THERAPY
210 - COST-EFFECTIVENESS OF NNRTI COMPARED WITH PI CONTAINING FIRST-LINE HAART REGIMENS IN UK NPMS-HHC CLINICS...
211 - MEASURING HEALTH STATUS AND QUALITY OF LIFE IN PATIENTS WITH HIV/AIDS: DOES THE LENGTH OF RECALL TIME...
212 - GENOTYPIC INHIBITORY QUOTIENT AS BEST PHARMACOKINETIC/PHARMACODYNAMIC PREDICTOR OF VIROLOGICAL RESP...
213 - THE CLINICAL AND ECONOMIC EFFECTS OF CONDUCTING RESEARCH WITHIN A CLINICAL SETTING
214 - EFFECTS OF SWITCHING FROM FIXED DOSE ZIDOVUDINE/LAMIVUDINE (CBV) TO FIXED DOSE TENOFOVIR DF/EMTRICITABINE...